Primary Medication Reconciliation Service Provided by Clinical Pharmacist for Chronic Kidney Disease in Our Hospital / 中国药学杂志
Chinese Pharmaceutical Journal
; (24): 2148-2151, 2018.
Article
em Zh
| WPRIM
| ID: wpr-858129
Biblioteca responsável:
WPRO
ABSTRACT
OBJECTIVE: To evaluate the efficacy of medication reconciliation (MR) service provided by clinical pharmacist for chronic kidney disease(CKD).METHODS: Patients with CKD administered in department of nephrology between Dec, 2017 and Mar. Total of 2018 who met the inclusion criteria were given MR service, and the newest Pharmaceutical Care Network Europe (PCNE) V8.02 classification scheme was constructed for drug related problems (DRP) to analysis and summary.RESULTS: MR was conducted 48 times (accounted for 80%) on 60 patients during the study period. Total of 59 medication DRP were identified. The most common DRP was treatment effectiveness (accounted for 84.75%), there were 54 causes (accounted for 76.06%) were prescribing in 71 causes, all the causes were classified as likely to cause level 1 harm (accounted for 84.75%), clinical pharmacists made 145 interventions, 102 (70.34%) of these were completely accepted and implement.CONCLUSION: DRPs are common in CKD patients, clinical pharmacists should provide MR for CKD patients, and conducted as routine work.
Texto completo:
1
Índice:
WPRIM
Tipo de estudo:
Prognostic_studies
Idioma:
Zh
Revista:
Chinese Pharmaceutical Journal
Ano de publicação:
2018
Tipo de documento:
Article